exenatide + glucagon

Exenatide + glucagon refers to a combination of two peptide hormones with distinct but potentially complementary mechanisms. Exenatide is a synthetic analog of glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist, increasing glucose-dependent insulin secretion, suppressing inappropriate glucagon secretion, delaying gastric emptying, and reducing food intake. It is primarily used for the management of type 2 diabetes mellitus[1][2][5]. Glucagon itself is a hormone that raises blood glucose levels by stimulating hepatic glucose production; it is typically used in the treatment of severe hypoglycemia. While both agents are individually approved drugs, there is no evidence from the provided sources or current clinical practice guidelines that an exenatide + glucagon fixed-dose combination product exists or has been developed for any indication.